The global high barrier packaging films for pharmaceuticals market size is projected to exceed USD 812.5 million by 2033. Throughout the projection period, the market is estimated to register a CAGR of 5.3%. Presently, the market is anticipated to gain market value of USD 484.8 million in 2023.
Key market characteristics observed in the global market for high barrier packaging films for pharmaceuticals include high investment in research and development with regard to innovative packaging formats and advanced materials. The market volume for global high barrier packaging films for pharmaceuticals is expected to expand 1.5X during the forecast period.
| Attributes | Details |
|---|---|
| High Barrier Packaging Films for Pharmaceuticals Market Size (2023) | USD 484.8 million |
| Projected Market Value (2033) | USD 812.5 million |
| Global Market Growth Rate (2023 to 2033) | 5.3% CAGR |
| Collective Value Share of Top 5 Companies in High Barrier Packaging Films for Pharmaceuticals Industry (2023E) | 12.90% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global high barrier packaging films for the pharmaceuticals market are characterized by the application of the barrier material. Blisters, bags, and pouches are packaging formats in which barrier materials are generally incorporated. Blisters are majorly preferred for solid pharmaceuticals due to the unit dosing format, and several benefits of unit dosing format over bulk packaging. Bags & pouches are preferred for pharmaceutical powders and pharmaceuticals in bulk.
European region provides a large market for high barrier packaging films for pharmaceutical blisters due to a very high preference for blister packaging over any other packaging format for pharmaceuticals, while North America provides a large market for high barrier packaging films for pharmaceutical bags and pouches.
EVOH and polyamide are the highly preferred materials for high barrier applications, while their usage is limited by high cost and low availability. Thus, other materials such as polypropylene, PVC, aluminum, and others are incorporated due to moderate barrier properties and high physical endurance.
On the basis of product type, the global high barrier packaging films market for pharmaceuticals is segmented into cold formable films, co-extruded films, and thermo-formable films. The co-extruded films market segment is estimated to account for the largest share of high barrier packaging film demand for pharmaceuticals. This segment is primarily driven by the economic production of multilayer films with significant physical properties.
Cold formable films possess better physical properties than co-extruded films, while the segment is restrained by the high cost of production. The segment is anticipated to remain in the introductory phase in the global market. Thermo-formable films are the most economical solution for high barrier packaging, majorly preferred by the regional emerging players.
On the basis of material type, the global high barrier packaging films market for pharmaceuticals is segmented into aluminum, PVC/PVdC, polypropylene, EVOH, polyamide, PET, polyethylene, and others (COC, PCTFE, etc.). The polypropylene segment is estimated to account for the largest market share with over 25% of the global market share by the year 2022.
Even though EVOH and polyamide possess much better barrier properties than polypropylene, the application of these materials is restrained by the high cost of material and low availability. Thus, materials with moderate barrier properties such as polypropylene, polyethylene, aluminum, and other materials are incorporated, which are abundant in availability and cost much lower.
| Region | North America |
|---|---|
| Market Share % 2022 | 32.1% |
| Market Size (USD million) by 2023 | USD 155.62 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 260.81 million |
| Region | Europe |
|---|---|
| Market Share % 2022 | 29.6% |
| Market Size (USD million) by 2023 | USD 143.50 million |
| Market Size (USD million) by End of Forecast Period (2033) | USD 240.5 million |
North America has always been at the topmost position in the pharmaceutical industry. As such, high-grade packaging is one of the mandates. This, in turn, calls for higher demand for high barrier packaging films for pharmaceuticals. With unadulterated medicines needed to reach far and wide, high barrier packaging films prove to be a good option. Europe stands second with Belgium and Denmark diverting a sizable percentage of their GDP towards pharmaceuticals.
| Asian Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 6.8% |
| India | 7.1% |
The Asian region is also expected to move around at a remarkable rate going forward. This is due to rising medical tourism in countries like Malaysia, Singapore, Thailand, India, and China. Plus, healthcare infrastructure is being upgraded at a better pace than it happened before.
Latin America is witnessing growth due with Brazil and Argentina being the epicenter. Middle and East Africa is also expected to get into the mainstream on the count of revenue generation. Overall, the region-wise scenario is a healthy one.
The global high barrier packaging films for the pharmaceuticals market are witnessing organic growth in the wake of strict regulations being enforced regarding safety.
Key Developments in the High Barrier Packaging Films for Pharmaceuticals Market:
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Germany, the United Kingdom, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, China, Japan, South Korea, Australia, New Zealand, Egypt, North Africa, South Africa, and GCC Countries |
| Key Market Segments Covered | Product, Material, Adhesion, and Region |
| Key Companies Profiled | Amcor plc; Bemis Company, Inc.; Sealed Air; KUREHA CORPORATION; FLAIR Flexible packaging Corporation; WINPAK Ltd.; MULTIVAC; DuPont, BERNHARDT Packaging & Process; Sonoco Products Company; Sigma Plastics Group; Perlen Packaging; OLIVER; Berry Global Inc.; Toray Plastics, Inc.; Schur Flexibles Holding GesmbH; ACG; Shrinath Rotopack Pvt. Ltd. |
| Pricing | Available upon Request |
The market is expected to secure a valuation of USD 484.8 million in 2023.
Europe is expected to dominate the market.
The growth potential of the market is 12.90% through 2033.
North America is forecast to generate USD 155.62 million in revenue by 2023.
Berry Global Inc. and Toray Plastics Inc. are the top players in the market.
| Estimated Size, 2025 | USD 19.3 billion |
|---|---|
| Projected Size, 2035 | USD 28.3 billion |
| Value-based CAGR (2025 to 2035) | 3.9% |
| Estimated Size, 2024 | USD 3.4 billion |
|---|---|
| Projected Size, 2034 | USD 4.9 billion |
| Value-based CAGR (2024 to 2034) | 3.5% |
Explore Plastic Packaging Insights
View Reports
High Barrier Packaging Films for Pharmaceuticals Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
